4.7 Article

Exosomal ncRNAs facilitate interactive ?dialogue? between tumor cells and tumor-associated macrophages

Journal

CANCER LETTERS
Volume 552, Issue -, Pages -

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2022.215975

Keywords

Biomarkers; Drug delivery; Tumor microenvironment; Macrophage polarization; Natural compounds; Clinical trials

Categories

Ask authors/readers for more resources

The review summarizes the dual effects of exosomal ncRNAs on tumor cells and TAMs, and discusses the application of exosomal ncRNAs as potential diagnostic or prognostic markers and drug delivery systems.
As a biological carrier, exosomes participate in the communication between various kinds of cells, and can mediate the interactive 'dialogue' between tumor cells and tumor-associated macrophages (TAMs). TAMs are the most abundant cell population in the tumor stroma and are an important part of the tumor immune microen-vironment. Various stimulating factors in the tumor microenvironment influence the polarization of TAMs into multiple phenotypes, such as M1 and M2. It plays a dual role in tumor immunity by both promoting and inhibiting tumor growth. Exosome-encapsulated non-coding RNAs (ncRNAs) participate in the interactive 'dia-logue' between exosome-mediated TAMs and tumor cells. Tumor-derived exosomal ncRNAs can promote macrophage polarization, whereas exosomal ncRNAs derived from TAMs can affect tumor proliferation, metastasis, angiogenesis, and chemotherapy resistance. The present review summarizes the dual effects of exosomal ncRNAs on tumor cells and TAMs, and discusses the application of exosomal ncRNAs as a potential diagnostic or prognostic marker and drug delivery system, to provide a new perspective and potential therapeutic drugs on targeting exosomes and macrophages in the treatment of tumors.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Pharmacology & Pharmacy

Natural Polysaccharides and Their Derivates: A Promising Natural Adjuvant for Tumor Immunotherapy

Ye Li, Xiaomin Wang, Xiaoran Ma, Cun Liu, Jibiao Wu, Changgang Sun

Summary: Polysaccharides, as adjuvant drugs in cancer immunotherapy, can activate immune cells, regulate adaptive immune pathways, and improve immune suppression, suggesting a promising future in cancer therapy.

FRONTIERS IN PHARMACOLOGY (2021)

Review Cell Biology

Role of Flavonoids in the Treatment of Iron Overload

Xiaomin Wang, Ye Li, Li Han, Jie Li, Cun Liu, Changgang Sun

Summary: Iron overload is a high risk factor for many diseases, while flavonoids have been found to affect iron status and may act as potential complementary therapies.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Review Oncology

Role of macrophages in tumor progression and therapy (Review)

Yiwei Xu, Xiaomin Wang, Lijuan Liu, Jia Wang, Jibiao Wu, Changgang Sun

Summary: The number and phenotype of macrophages play a crucial role in tumor growth, progression, and prognosis. Targeting tumor-associated macrophages can improve the efficacy of cancer treatment by modifying the tumor microenvironment and reducing immunosuppression.

INTERNATIONAL JOURNAL OF ONCOLOGY (2022)

Review Medicine, Research & Experimental

Natural compounds: A new perspective on targeting polarization and infiltration of tumor-associated macrophages in lung cancer

Xintong Zhou, Xiaomin Wang, Qi Sun, Wenfeng Zhang, Cun Liu, Wenzhe Ma, Changgang Sun

Summary: This paper discusses the infiltration and polarization effects of natural compounds on lung cancer tumor-associated macrophages (TAMs), provides a detailed classification and systematic review of natural compounds, and summarizes the bias of different kinds of natural compounds by affecting their antitumor mechanism of TAMs, with the aim of providing new perspectives and potential therapeutic drugs for targeted macrophages in the treatment of lung cancer.

BIOMEDICINE & PHARMACOTHERAPY (2022)

Review Medicine, Research & Experimental

New insights from the single-cell level: Tumor associated macrophages heterogeneity and personalized therapy

Xiaomin Wang, Yiwei Xu, Qi Sun, Xintong Zhou, Wenzhe Ma, JiBiao Wu, Jing Zhuang, Changgang Sun

Summary: Tumor-associated macrophages (TAMs) play a crucial role in tumor microenvironment and their invasion in tumors is closely related to poor prognosis. However, studying TAMs' heterogeneity and developing drugs targeting them is challenging. Single-cell RNA sequencing (scRNA-seq) provides an efficient detection method to reveal TAMs' heterogeneity and offers more accurate information for TAM-related studies.

BIOMEDICINE & PHARMACOTHERAPY (2022)

Review Pharmacology & Pharmacy

Flavonoids regulate tumor-associated macrophages - From structure-activity relationship to clinical potential (Review)

Qi Sun, Qi Liu, Xintong Zhou, Xiaomin Wang, Huayao Li, Wenfeng Zhang, Hailian Yuan, Changgang Sun

Summary: In recent years, the focus of tumor therapy has shifted to multi-mode interventions in the tumor microenvironment. Flavonoids have diverse immunomodulatory and anti-cancer activities in the tumor microenvironment. This study provides a comprehensive understanding of how flavonoids regulate tumor-associated macrophages and discusses their potential implications in cancer immunotherapy.

PHARMACOLOGICAL RESEARCH (2022)

Review Immunology

Tumor accomplice: T cell exhaustion induced by chronic inflammation

Liguang Fang, Kunjing Liu, Cun Liu, Xiaomin Wang, Wenzhe Ma, Wenhua Xu, Jibiao Wu, Changgang Sun

Summary: This article summarizes the dynamic evolution of inflammation from acute to chronic in tumor development and its impact on T cells. Understanding the state of inflammation and T cells at different stages is crucial for clinical decision-making and improving the efficacy of tumor immunotherapy.

FRONTIERS IN IMMUNOLOGY (2022)

Review Oncology

Small extracellular vesicles: Non-negligible vesicles in tumor progression, diagnosis, and therapy

Xinru Zhou, Yin Jia, Chuanbin Mao, Shanrong Liu

Summary: Small extracellular vesicles (sEVs), such as exosomes, have emerged as crucial targets for liquid biopsy and promising drug delivery vehicles in tumor progression. They can serve as biomarkers for tumor diagnosis and as drug carriers for cancer treatment.

CANCER LETTERS (2024)

Article Oncology

HMGB1 in the interplay between autophagy and apoptosis in cancer

Ruochan Chen, Ju Zhu, Xiao Zhong, Jie Li, Rui Kang, Daolin Tang

Summary: The interplay between autophagy and apoptosis plays a crucial role in tumorigenesis and cancer therapy, with HMGB1 serving as a key regulator in these processes.

CANCER LETTERS (2024)

Article Oncology

Epigenetic inhibition of CTCF by HN1 promotes dedifferentiation and stemness of anaplastic thyroid cancer

Zongfu Pan, Xixuan Lu, Tong Xu, Jinming Chen, Lisha Bao, Ying Li, Yingying Gong, Yulu Che, Xiaozhou Zou, Zhuo Tan, Ping Huang, Minghua Ge

Summary: This study uncovered the emerging role of HN1 in promoting dedifferentiation of anaplastic thyroid cancer (ATC) cells. HN1 negatively regulated the thyroid differentiation markers and had an inhibitory effect on the transcriptional activation of CTCF, thereby influencing the chromatin accessibility of thyroid differentiation genes.

CANCER LETTERS (2024)

Article Oncology

Autophagy machinery in glioblastoma: The prospect of cell death crosstalk and drug resistance with bioinformatics analysis

Yi Qin, Shengjun Xiong, Jun Ren, Gautam Sethi

Summary: Autophagy plays an important regulatory role in glioblastoma, and its dysregulation can lead to drug resistance and radioresistance. It also affects stem cell characteristics, overall growth, and metastasis. Therefore, autophagy is a promising target for glioblastoma therapy.

CANCER LETTERS (2024)

Article Oncology

Elevated 2-oxoglutarate antagonizes DNA damage responses in cholangiocarcinoma chemotherapy through regulating aspartate beta-hydroxylase

Katsuya Nagaoka, Xuewei Bai, Dan Liu, Kevin Cao, Joud Mulla, Chengcheng Ji, Hongze Chen, Muhammad Azhar Nisar, Amalia Bay, William Mueller, Grace Hildebrand, Jin-Song Gao, Shaolei Lu, Hiroko Setoyama, Yasuhito Tanaka, Jack R. Wands, Chiung-Kuei Huang

Summary: This study found that serum 2-OG levels in cholangiocarcinoma patients are associated with the effectiveness of chemotherapy. Patients with progressive disease showed significantly higher levels of serum 2-OG compared to stable disease and partial response patients. The study also revealed that overexpression of ASPH mimics the effects of 2-OG, and knockdown of ASPH improves chemotherapy. Targeting ASPH enhances the effects of chemotherapy by modulating ATM and ATR, two key regulators of DDRs.

CANCER LETTERS (2024)